MultiCTR Randomized Double-Blind Double-Dummy Dose-Ranging Study to Evaluate Clinical Efficacy/Safety of 2 Doses of DR 6MP for Targeted Ileal Delivery vs Purinethol in Non-Steroid Dependent Patients w/Moderately Active Crohn's Disease.
Phase of Trial: Phase I/II
Latest Information Update: 14 Mar 2013
At a glance
- Drugs Mercaptopurine (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 07 Jun 2011 Planned end date changed from 1 Dec 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 08 Nov 2010 Actual initiation date (November 2010) added as reported by ClinicalTrials.gov.
- 08 Nov 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.